Molecular Diagnostics
Combined Screening Suggested to Better Detect ALK Rearrangements in Samples from Non-Small-Cell Lung Cancer Patients
Anaplastic lymphoma kinase rearrangements occur in 1% to 7% of non-small-cell lung cancers, but nearly 25% of samples from NSCLC patients with ALK rearrangements were not identified when analyzed by either fluorescent in situ hybridization or immunohistochemistry. More...12 Mar 2014
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Hemodynamic System Monitor
OptoMonitor
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
In Other News
Genetic Screening Can Identify Men at Higher Risk of Aggressive Prostate Cancer
Whole-Genome Testing Helps Identify Breast Cancer Treatments
DNA Reference Samples Will Regularize Diagnosis of Rett Syndrome
Noninvasive Prenatal Testing Detects Most Chromosomal Abnormalities
Noninvasive Blood Test for Fetal Trisomies Now Certified for Multiple Pregnancies
Dako and Amgen Collaborate to Develop New Diagnostic Test
Superior Single-Cell Library Preparation Technology Now Available for Additional Platforms
New Genetic Forms of Neurodegeneration Discovered
New Tool Developed to Identify Genetic Risk Factors
Dedicated Blood DNA Collection Tube Receives European Marketing Approval
Next-Generation Breast Cancer Tests Provide More Precise Prognosis
Fetal Hypoxia Determined by mRNAs Abundance in Maternal Blood
DNA Health Monitoring Campaign Launched
Prognostic Test Predicts Prostate Cancer-Specific Death and Metastases
Germline and Somatic Variants Analyzed in Ovarian Cancer
Molecular Blood Test Detects Lung Cancer
Clinical Performance Supports New Diagnostic Assay for Multiple Sclerosis
DNA-Barcode Profiling Identifies Cancer Biomarkers in Fine Needle Aspirates
Transformative New System Brings Whole Genome Sequencing to the Desktop
Novel Subtyping Assay Detects Clostridium Virulence Genes
Amgen and Illumina Collaborate on Oncology Companion Diagnostic Test
DNA-Enrichment Technology May Help Replace Biopsies for Cancer Mutation Testing
Response of Early Stage Breast Cancer to Chemotherapy Predicted
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.